Cardio-renal drugs advisory cmte.
Executive Summary
Agenda for Sept. 29-30 meeting includes review of DuPont/American Critical Care's short-acting I.V. beta-blocker Brevibloc (esmolol), for use in controlling blood pressure and pulse rate during anesthesia; a twice-daily formulation of Schering Plough's anti-arrhythemic Quinibid (quinidine gluconate); Syntex' calcium channel blocker Cardene (nicardipine); and Elan's sustained release methyldopa.